The pneumococcus: host-organism interactions and their implications for immunotherapy and immunoprophylaxis

Perry, F E; Catterall, J R
October 1994
Thorax;Oct1994, Vol. 49 Issue 10, p946
Academic Journal
No abstract available.


Related Articles

  • What Are the Implications for Childhood Pneumonia of Successfully Introducing Hib and Pneumococcal Vaccines in Developing Countries? Scott, J. Anthony G.; English, Mike // PLoS Medicine;Apr2008, Vol. 5 Issue 4, pe86 

    The authors look to the future and imagine the implications of a successful vaccination campaign againstH. influenzae type b and pneumococcus.

  • A new look for the 1990s. Pardoll, Drew M. // Nature;6/2/1994, Vol. 369 Issue 6479, p357 

    Reports on the implications of the successful identification of tumor peptide antigens restricted by class I molecules of the major histocompatibility complex (MHC). Understanding of immune system's interaction with tumor cells; Development of antigen-specific immunotherapies.

  • Commentary: Immunological Treatments for Autism: In Search of Reasons for Promising Approaches. Zimmerman, Andrew W. // Journal of Autism & Developmental Disorders;Oct2000, Vol. 30 Issue 5, p481 

    Comments on the trends and developments pertaining to the immunological treatment of autism. Clinical indications of neuroimmune interactions in autism; Development of immunotherapies for autism; Use of corticosteroids; Description and diagnosis of autism; Implications for treatment.

  • Immunology of Human Melanoma: Tumor-Host Interaction and Immunotherapy (Book). Armstrong, Cheryl // Journal of Investigative Dermatology;Feb97, Vol. 108 Issue 2, p236 

    Reviews the book "Immunology of Human Melanoma: Tumor-Host Interaction and Immunotherapy," edited by Michele Maio.

  • Development of cancer immunotherapies based on identification of the genes encoding cancer... Rosenberg, Steven A. // JNCI: Journal of the National Cancer Institute;11/20/96, Vol. 88 Issue 22, p1635 

    Presents a study on the development of cancer immunotherapies based on the identification of genes encoding cancer regression antigens. Molecular identification of tumor antigens; Generation of antitumor effector cells; Implications on the development of cancer immunotherapies.

  • An Overview of Immunotherapy for Allergic Disease: New Developments and Future Strategies. Prescott, Susan L.; Thornton, Catherine A. // Medicinal Chemistry Reviews - Online;Apr2004, Vol. 1 Issue 2, p163 

    The dramatic increase in allergic disease is now an enormous healthcare burden in many countries. Because most current treatment strategies are directed only at controlling the symptoms of these common, disabling and potentially life threatening conditions, there is now a pressing need to define...

  • An Update of Immunotherapy for Specific Allergies. Prescott, Susan L.; Jones, Catherine A. // Current Drug Targets - Inflammation & Allergy;Mar2002, Vol. 1 Issue 1, p65 

    Allergic diseases are common, disabling and potentially life threatening. The processes that lead to production of excessive allergen-specific IgE production are highly complex and heterogeneous. While current treatment strategies are limited, recent technological advances have provided a better...

  • Antimicrobial Resistance in Streptococcus Pneumoniae, Taiwan. Po-Ren Hsueh; Kwen-Tay Luh // Emerging Infectious Diseases;Dec2002, Vol. 8 Issue 12, p1487 

    Provides information on a study which discussed the trends of pneumococcal resistance in Taiwan. Information on the antibiotic-resistant pneumococcus; Disease burden and severity; Discussion of the occurrence of multi-drug resistance; Implication of antibiotic-resistance in cases of respiratory...

  • Genetic instability and tumor cell variation: Implications for immunotherapy. Fenton, Robert G.; Longo, Dan L. // JNCI: Journal of the National Cancer Institute;2/15/95, Vol. 87 Issue 4, p241 

    Discusses the implications of immunotherapy in genetic instability and tumor cell variation. Nature of cancer as a genetic disease; Efficacy of immunotherapy in cancer treatment; Difficulty in inducing antitumor responses; Observing I MHC allospecificities in tumor histologies; Tumor escape...

  • Immunotherapy of Chemically-Induced Tumors in the Hamster Cheek Pouch with Dinitrochlorobenzene. MARSHACK, MARTIN; TOTO, PATRICK; KERMAN, RONALD // Journal of Dental Research;Apr1978, Vol. 57 Issue 4, p625 

    Immune stimulation with an agent such as dinitrochlorobenzene (DNCB) may delay chemcal carcinogenesis. Dimethylbenzanthracene (DMBA) was used to chemically induce tumors in the hamster buccal pouch. Hamsters were studied for the effect of DNCB sensitization in the buccal pouch prior to or after...


Read the Article


Sign out of this library

Other Topics